Prapela
PrivateLast Round
Series A
Apr 22, 2025
Total Funding Raised
$8.56M
Company Overview
Prapela is a medical device company that develops and commercializes innovative stimulation therapy to improve breathing and oxygenation in newborns.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Health IoT
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Prapela Comparables
Compare Prapela with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Spark Biomedical Inc | 83% | |
| smallTalk Technology, Inc. | 73% | |
| AquaWomb | 62% |
Prapela Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Apr 22, 2025 | ||||
| Grant | Apr 6, 2023 | ||||
| Grant | Jun 9, 2021 | ||||
| Grant | Apr 29, 2021 | ||||
| Grant | Aug 27, 2019 | ||||
Grant | Aug 27, 2019 |
Key People
Founding team and executive leadership
Prapela Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Institute on Drug Abuse | Grant |
| Alliance for Pediatric Device Innovation | Grant |
| NIH Helping to End Addiction Long-term (HEAL) Initiative | Grant |
| NIH RADx | Grant |
| Massachusetts Life Sciences Center | Grant |
| Ohio Third Frontier | Grant |
| Maine Technology Institute | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 6, 2023
$4M grant round led by National Institute on Drug Abuse and NIH RADx.
- Jun 9, 2021
Secured $3M from the National Institute on Drug Abuse.
Prapela Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Prapela's valuation, stock price, and market status.
Is Prapela a public or private company?
Prapela is a private company.
What is the current stock price of Prapela?
Prapela is a private company, so its shares have no public market price. Caplight tracks Prapela's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Prapela worth (valuation)?
Valuation information for Prapela is not publicly available.
Can I buy Prapela stock?
Prapela shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Prapela's last funding round?
Prapela's most recent funding round was Series A on April 22, 2025.
Who are the main investors in Prapela?
Key investors in Prapela include NIH RADx, Massachusetts Life Sciences Center, Ohio Third Frontier, Maine Technology Institute, National Institute on Drug Abuse.
Will Prapela IPO soon?
No public IPO plans have been announced for Prapela.
How can I track Prapela secondary market activity?
Caplight tracks bids, offers, and trades in Prapela's shares on secondary markets.